Navigation Links
B. Braun and DaVita Sign Dialysis Agreement
Date:11/18/2013

BETHLEHEM, Pa., Nov. 18, 2013 /PRNewswire/ -- B. Braun Medical Inc. (B.Braun) announced today that it has entered into an agreement with DaVita Healthcare Partners for the supply of dialysis products. Under the new agreement, DaVita will purchase B.Braun Dialog+ dialysis equipment and associated disposables to fill a portion of its product requirement. 

"We are very pleased to continue our business relationship with DaVita who has a long standing reputation for high quality dialysis care," said Samuel Amory, Vice President, at B.Braun. "DaVita has very high standards for the products they select and we are extremely proud that Dialog is one of those products," added Amory.

In addition to the Dialog+ Hemodialysis System, B.Braun's dialysis product line offers a wide array of disposable products that allow healthcare professionals to tailor treatments for their patients.

B.Braun has been a leader in providing the dialysis community with innovative products for over 35 years.  The DialogHemodialysis System incorporates the most advanced state-of-the art technology in dialysis. As a manufacturer and distributor of hemodialysis equipment and related disposables, including the Diacap @ Polysulfone® dialyzers, Medisystems' Streamline Bloodlines, the Renal Therapies Division of B.Braun is committed to the continued development of high quality products for hemodialysis and continuous renal replacement therapy supported by a team of clinical nurses, field service personnel, customer service and 24/7 technical assistance.

For more information on the Dialog+ Hemodialysis System, Adimea Technology and B.Braun's complete line of dialysis products click here or call 800.848.2066.

About B. Braun

B. Braun Medical Inc. (B.Braun), a leader in infusion therapy and pain management, develops, manufactures, and markets innovative medical products and services to the healthcare industry. The Company is committed to eliminating preventable treatment errors and enhancing patient, clinician and environmental safety. Guided by its "Sharing Expertise®" philosophy, B.Braun continuously exchanges knowledge with customers, partners and clinicians to address the critical issues of improving care and lowering costs.

The B.Braun Group of Companies in the U.S. includes B.Braun, B.Braun Interventional Systems, Aesculap® and CAPS®. B.Braun's U.S. headquarters is located in Bethlehem, Pennsylvania. The B.Braun Group of Companies employs more than 46,000 employees in more than 50 countries throughout the world. To learn more about B.Braun visit www.BBraunUSA.com.    


'/>"/>
SOURCE B. Braun Medical Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. B. Braun to Launch New Level of Water Treatment Technology at ASN
2. B. Braun Launches 3L Sterile Water for Irrigation Container
3. B. Braun to Showcase Its Safety-Engineered IV Therapy Portfolio at INS
4. B. Braun Purchases Land To Build New North American Headquarters
5. B. Braun Signs U.S. Distributor Agreement for Dialysis Water Purification Systems
6. B. Braun Receives FDA Approval For New Large-Volume Irrigation Containers
7. B. Braun Receives FDA Approval For New Large-Volume Intravenous Containers
8. B. Braun to Showcase Its Safety-Engineered IV Therapy Portfolio at AVA
9. B. Braun Awarded Premier Healthcare Alliance Contract for Dual-Source IV
10. Patient and Healthcare Worker Safety Major Areas of Focus at B.Braun
11. B. Braun Smart Infusion Pump Technology to be Featured in Integrating the Healthcare Enterprise (IHE) Interoperability Demonstration at AAMI 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... 2016  Breckenridge Pharmaceutical, Inc. announced today that ... with development and manufacturing partner Gland Pharma Limited ... of this agreement, Breckenridge will market and distribute ... the United States . The deal includes ... products cover a wide range of indications.  This ...
(Date:12/5/2016)... Oregon and PUNE, India , ... new report by Allied Market Research, titled, "Global Cancer Biomarkers ... global revenue of cancer biomarkers market is projected to reach ... a CAGR of 13.3% from 2016 to 2022. Omic technologies ... in 2015 and is expected to maintain its dominance during ...
(Date:12/5/2016)... Dec. 5, 2016  Recently Zymo Research announced ... predictor, known as Horvath,s Clock. Based on this ... analysis service to academic and biopharma scientific researchers ... sample, other than sperm. The service ... biological age versus chronological age following drug treatments ...
Breaking Medicine Technology:
(Date:12/6/2016)... Albuquerque, NM (PRWEB) , ... December 06, 2016 ... ... awarded JumpStart Autism Center with an Award of Distinction, recognizing the organization as ... needs providers that excel in the areas of clinical quality, staff satisfaction and ...
(Date:12/6/2016)... ... December 06, 2016 , ... Experimentation involving human stem cells ... due to its potential for revolutionizing human disease treatment. There are multiple HSC ... stem cells (hiPSCs). , Both platforms have distinct advantages and disadvantages, but ...
(Date:12/6/2016)... , ... December 06, 2016 , ... ... one-stop portal for all the knowledge resources, including white papers, guides, handbooks, case ... more. , To access more than 9,000 documents, webinars and videos available ...
(Date:12/6/2016)... , ... December 06, 2016 , ... 'Tis the season ... daily routines. That means it's also the season when eating healthy, staying active, and ... diabetes) on schedule is harder to do. , "Shopping trips, parties and family ...
(Date:12/6/2016)... ... 06, 2016 , ... Specialty Technical Publishers (STP) and Specialty ... Consortium (IAPC) EHS audit protocol for Great Britain . Leading companies around ... EHS regulatory obligations and rapidly collect, share, archive, and export audit findings in ...
Breaking Medicine News(10 mins):